The chemotherapy metabolite acrolein upregulates thrombin generation and impairs the protein C anticoagulant pathway in animal-based and cell-based models

Oxazaphosphorines: new therapeutic strategies for an old class of drugs

(2010) Bérénice Giraud et al.   Expert Opinion on Drug Metabolism & Toxicology

Daunorubicin induces procoagulant activity of cultured endothelial cells through phosphatidylserine exposure and microparticles release

(2010) Huibo Li et al.   THROMBOSIS AND HAEMOSTASIS

Cancer cell–derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo

(2009) Grace M. Thomas et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Chemotherapeutic agents doxorubicin and epirubicin induce a procoagulant phenotype on endothelial cells and blood monocytes

(2009) L. L. SWYSTUN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Acrolein consumption induces systemic dyslipidemia and lipoprotein modification

(2009) Daniel J. Conklin et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Contribution of Host-Derived Tissue Factor to Tumor Neovascularization

(2008) Joanne Yu et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Early changes in the haemostatic and procoagulant systems after chemotherapy for breast cancer

(2008) C C Kirwan et al.   BRITISH JOURNAL OF CANCER

Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation

(2008) M. DAVILA et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Endothelial Injury, an Intriguing Effect of Methotrexate and Cyclophosphamide During Hematopoietic Stem Cell Transplantation in Mice

(2008) L. Zeng et al.   TRANSPLANTATION PROCEEDINGS

Antithrombin activity is inhibited by acrolein and homocysteine thiolactone: Protection by cysteine

(2007) Alejandro Gugliucci   LIFE SCIENCES